Shivang Dave

Shivang Dave, Ph.D.


Shivang R. Dave, PhD, is CEO and Co-Founder of PlenOptika, which designs and produces tools to vastly expand access to vision care globally. As CEO, Shivang led PlenOptika’s growth from startup to an international company with products in global distribution, improving vision for millions of patients worldwide. A passionate advocate for technology innovation to address care disparities, Shivang has positioned PlenOptika as a thought leader in vision health research, optical care, and global health policy with strong strategic partnerships in academia, industry, and public health. He earned his undergraduate degree from UC Berkeley and doctorate in Bioengineering and Nanotechnology from the University of Washington, and completed an advanced research fellowship at the Massachusetts Institute of Technology. A veteran of two commercial startups prior to PlenOptika, Shivang mentors rising entrepreneurs by sharing his experiences and insights regarding innovation, translational medicine, and leadership.

Daryl Lim, Ph.D.


Daryl Lim has been involved in both technical and business sides of the biomedical industry. He received a B.S. in Physics from the University of Leipzig and a Ph.D. in Biomedical Engineering from Boston University. Following that, he did a postdoctoral fellowship at MIT where he developed diagnostic technologies for ophthalmology and oncology. As a management consultant at McKinsey & Company, Daryl worked with some of the largest companies in the med-tech, healthcare, and pharma sectors in a variety of projects spanning operations, strategy, organization, and more.

Eduardo Lage, Ph.D.


Eduardo Lage, a native of Spain, received his undergraduate degree in Electronic Engineering from the University of Alcala (Madrid) and his PhD in Medical Imaging from the University Politecnica of Madrid. He began his career in Medical Imaging by joining the Medical Imaging Lab of the Gregorio Marañon Hospital to help in the development of a Positron Emission Tomography (PET) system for small-animal imaging. From that time, Eduardo Lage has focused his career on exploring innovative approaches for molecular imaging. Dr. Lage has led or participated in the design and development of various preclinical scanners (PET, SPECT, CT and multimodality systems) which have been commercialized by several companies such as SEDECAL S.A. (Madrid) and General Electric (USA).

John Strobel

John Strobel, MBA

Vice President, Sales

Oscar Lazaro, MBA

Vice President, Strategic Growth Initiatives

Eric Norman

Eric Norman

Vice President, Communications

Board of Directors

Rohit Gupta

Rohit Gupta

Managing Partner, Future Communities Capital

Marta Gaia-Zanchi

Marta Gaia-Zanchi, PhD

Founder & Managing Partner, Nina Capital

Board Observers

Andrew Maguire

Andrew Maguire

Partner, Oakhouse Partners

Nikita Imennov, PhD, CFA, FRM

Vice President, Senior Quant – Fixed Income Beta Desk, State Street Global Advisors

Board Advisor

Will Febbo

CEO, OptimizeRX Corporation

Industry & Clinical Advisory Board

Jessica Byrd

Jessica Byrd, COT, OSC

Clinical Trainer, Georgia Eye Partners

Gary Chu, OD

Gary Y. Chu, OD

Vice President, Professional Affairs at New England College of Optometry

Darius Moshfeghi

Darius Moshfeghi, MD

Chief of Retina Division, Stanford University School of Medicine; Chief Medical Officer, WALDO

Dave Sattler

Dave Sattler

President at Dave Sattler Consulting Services; formerly, Director Professional Relations at Alcon

Huy Tran, OD

Huy Tran, OD

Associate Director, Medical Affairs at Regeneron

Tom Wong, OD

Thomas A Wong, OD

Associate Clinical Professor, Director of Clinical Externships, and Director of New Technologies at State University of New York College of Optometry